Nexobrid

Active Ingredient(s): Anacaulase-bcdb
FDA Approved: * December 28, 2022
Pharm Company: * MEDIWOUND, LTD
Category: Skin Care
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

NexobridNexobrid Topical Kit
NDC: 69866-2002
Labeler:
Vericel Corporation
NexobridNexobrid Topical Kit
NDC: 69866-2005
Labeler:
Vericel Corporation